Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00942240 · ClinicalTrials.gov registry record · Phase 1
Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects
A Phase 1 study, sponsored by Kubota Vision.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00942240 is a Phase 1 study that has completed, run by Kubota Vision. The registered enrollment target is 40 participants.
The verdict
NCT00942240, a Phase 1 study, has completed, sponsored by Kubota Vision.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and tolerability of repeated doses of a new investigational drug (ACU-4429) in healthy human subjects.
Interventions
- DRUG ACU-4429
- DRUG matching placebo tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00942240
The ClinicalTrials.gov registry entry for NCT00942240 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kubota Vision, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ACU-4429 is the first listed.
NCT00942240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00942240 about?
NCT00942240 is a clinical study titled "Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects". The purpose of this study is to evaluate the safety and tolerability of repeated doses of a new investigational drug (ACU-4429) in healthy human subjects.
What is the current status of trial NCT00942240?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2009-07. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00942240?
The interventions under investigation include: ACU-4429 (DRUG), matching placebo tablet (DRUG).
Who is sponsoring clinical trial NCT00942240?
This trial is sponsored by Kubota Vision, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.